Industrial Microbiology, a dynamic branch of microbiology, applies the power of microorganisms to transform industries across diverse sectors. Utilizing bacteria, fungi, and other microbes, it pioneers processes like fermentation, enzyme synthesis, and biofuel creation. This field stands at the forefront of food and beverage production, pharmaceuticals, and environmental stewardship.
In the realm of Industrial Microbiology, microbial alchemy is harnessed for the production of antibiotics, vaccines, and bio-based materials. Within this sphere, microbial biotechnology takes center stage, exploring genetic engineering and bioprocessing techniques for groundbreaking applications. The impact of Industrial Microbiology extends into pharmaceuticals, where it catalyzes the creation of life-saving medications. Moreover, Industrial Microbiologists spearhead advancements in environmental management, deploying microorganisms to break down pollutants in waste treatment processes.
This discipline is a beacon of innovation, constantly propelling eco-friendly solutions and pioneering new frontiers in biotechnology and industrial processes. As Industrial Microbiology continues to evolve, it remains a driving force, revolutionizing industries and shaping a sustainable future.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia